Research Grants
May 2002 . November 2002 . May 2003 . November 2003 . May 2004 . May 2005 . November 2005 . May 2006 . November 2006 . May 2007 . November 2007 . November 2008
5th Grant Competition - May, 2004
Twelve projects aimed at development of promising new cancer treatments received $6.9 million from the Cancer Research Fund. By funding 69 cancer research projects from 5 competitions the OCRN is providing a total of $33 million across 15 Ontario sites.
| Principal Investigator | Institution | Project Type/Title | Award* |
| Bramson, Jonathan | McMaster University | Translational: Interaction between conventional cancer therapy and gene-based cancer vaccines | $612,504 |
| Chambers, Ann | London Health Sciences Centre | Translational: Clinical and experimental studies of osteopontin and breast cancer - a translational program to examine its functional contribution to malignancy and its potential as a marker of progression and as a therapeutic target | $700,594 |
| Dick, John | University Health Network | Matching Funds: Mass spectrometer-based flow cytometer:methods and applications | $1,200,000 |
| Gauldie, Jack | McMaster University | Companion: Dendritic cell-based vaccine for therapy of CLL | $688,285 |
| O’Sullivan, Brian | University Health Network | Clinical: Phase II study of pre-operative intensity-modulated radiation therapy for lower limb soft tissue sarcoma | $228,235 |
| Petrik, Jim | University of Guelph | Translational: Role of the thrombospondin family in inhibiting ovarian tumour growth | $505,321 |
| Spaner, David | Sunnybrook & Women's College Health Science Centre | Translational: A novel protein kinase C modulator and interferon-alpha2b to enhance natural and vaccine-induced anti-tumor T cell responses in melanoma patients | $564,390 |
| Stewart, Keith | University Health Network | Translational: Identification of novel prognostic markers and molecular targets in myeloma | $540,000 |
| Sur, Ranjan | McMaster University | Translational: Photodynamic therapy and brachytherapy in palliation of advanced lung cancer | $589,680 |
| Tsao, Ming | University Health Network | Translational: Genomic profiles of lung cancer that predict prognosis and response to adjuvant chemotherapy | $587,880 |
| Ung, Yee | Toronto Sunnybrook Regional Cancer Centre | Clinical: Can PET CT coregistration imaging adequately determine the gross tumor volume and microscopic extension in non-small cell lung cancer patients for radical radiation therapy? | $253,800 |
| Wong, Shun | Sunnybrook & Women’s College Health Sciences | Translational: The neuroprotective role of erythropoietin in radiation-induced CNS injury | $$526,894 |
* Includes a value of 20 per cent added for institution overhead.